The Tohoku Journal of Experimental Medicine
Online ISSN : 1349-3329
Print ISSN : 0040-8727
ISSN-L : 0040-8727
Regular Contributions
Significance of Elevated Procollagen-III-Peptide and Transforming Growth Factor-β Levels of Bronchoalveolar Lavage Fluids from Idiopathic Pulmonary Fibrosis Patients
Nanako Hiwatari, Sanae Shimura, Kohei Yamauchi, Masayuki Nara, Wataru Hida, Kunio Shirato
Author information
JOURNAL FREE ACCESS

1997 Volume 181 Issue 2 Pages 285-295

Details
Abstract
Although both procollagen III aminopeptide (P-IIl-P) and transforming growth factor-β (TGF-β) are reported to be present in lung tissue and/or elevated in bronchoalveolar lavage fluid (BALF) from idiopathic pulmonary fibrosis (IPF) patients, we have little knowledge concerning the clinical significance of elevated P-III-P and TGF-β levels in BALF. Using a radioimmunoassay, we measured P-III-P and TGF-β in BALF from 48 IPF patients (16F and 32M, 59±2 years, mean± S.E.) who received BAL in our clinic over the past 13 years before glucocorticosteroid treatment. Among them, we could detect a significant amount of P-III-P (2.2± 1.0 U/ml; range 0.03 to 16.5 U/ml) in BALF in 18 of the patients (5F and 13M, 58±3 years) (group B), but not (0.03 U/ml or less) in the other 30 patients (11E and 19M, 59±2 years) (group A). Lymphocyte (%) and basophil (%) in BALF from group B was much larger than that from group A (33% vs. 8%, p<0.01). Group B showed a longer duration of onset to BAL (36 months vs. 23 months, p<0.05). TGF-β levels were obtained using an ELISA system kit from the same BALF samples. TGF-β was not detected in 10 patients (100 pg/ml or less) (3F and 7M, 59±4 years) (group I), while the remaining 38 patients showed a significant amount of TGF-β (329±44 pg/ml, range 100 to 1,360 pg/ml). The latter patients were further divided into two groups; group II 100 to 300 pg/ml (10F and 14M, 56±3 years) and group III 350 or more (3F and 11M, 63±2 years). Group III showed significantly better values in PaO2, Aa-DO2, %VC and %DLco, and smaller percentage of basophils in BALF than did groups I and/or II, whereas survival after BAL in group III was significantly shorter than in group I (31 vs. 19 months, p<0.05). There was no significant relationship between P-III-P and TGF-β levels in BALE. These findings suggest that elevated P-III-P level is accompanied by an increase in lymphocyte population in BALF from IPF patients, resulting in a longer duration of the disease, while elevated TGF-β level reflects alveolar inflammation at an earlier stage of the disease which induces a progression of the disease, resulting in a shorter survival in IPF patients.
Content from these authors
© 1997 Tohoku University Medical Press
Previous article Next article
feedback
Top